 |
|
Lux Capital Management is a New York-based venture capital firm focused on early stage investments in the physical and life sciences. Collectively, the investment team at Lux has started more than 20 companies including Nanosys, Vertex [VRTX], Illumina [ILMN], Caliper Technologies [CALP], Neurocrine Biosciences [NBIX], Lux Research, and Idun (acquired by Pfizer [PFE]). Robert Paull represents Lux Capital on Kala's Board of Directors. 
Polaris invests in seed, early stage and middle market companies in high growth industries. As the lead or co-lead investor, Polaris takes an active and long-term role in helping management teams build highly successful businesses. Polaris has over $3 billion under management and current investments in more than 90 companies. Kevin Bitterman, Ph.D. represents Polaris Venture Partners on Kala's Board of Directors. 
Third Rock Ventures is a premier venture firm focused on life sciences, investing and launching companies that make a difference in people's lives. Collaborating with entrepreneurs, the Third Rock team applies its deep expertise to establish the roadmap and building blocks for a rapidly growing and highly successful life sciences company. The Third Rock team has a unique vision and experience in building great companies, extensive academic and industry networks and a collective track record for creatively managing the value creation path to deliver exceptional performance. Bob Tepper, M.D. represents Third Rock Ventures on Kala's Board of Directors. |
|